Copley to introduce Child Alberta Idealised Throat at DDL

Copley Scientific has announced that it will introduce the new Child Alberta Idealised Throat for inhaler testing at Drug Delivery to the Lungs 24 along with its recently introduced TPK-R critical flow controller.

The child version of the Alberta Idealised Throat (AIT) is designed to provide cascade impactor data with greater in vivo relevance for pediatric patients. Both Alberta throats can be used to replace the standard USP induction port to obtain more realistic simulations of deposition in the upper respiratory tract.

Read the Copley Scientific press release.

Share

published on

December 9-December 11: DDL 2026, Edinburgh, Scotland

April 27-30: RDD Europe 2027, Antibes, France

May 30-June 2: ISAM Congress 2027, Dublin, Ireland

June 23: SMI London, London, UK